Paper10074183
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
Verschoor EJ and 11 others. J Virol, 1999. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance. Papers, record 10074183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10074183
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Acquired Immunodeficiency Syndrome | Major topic |
| HIV Envelope Protein gp120 | Major topic |
| HIV-1 | Major topic |
| ISCOMs | Major topic |
| Immunity, Cellular | Major topic |
| Polysorbates | Major topic |
| Squalene | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Chemistry, Pharmaceutical | |
| Humans | |
| Macaca mulatta | |
| Recombinant Proteins |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1718036 | Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. | Science | 1991 | https://conductscience.org/library/papers/1718036 | PubMed |
| 2 | 9325017 | In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations. | Cytokine | 1997 | https://conductscience.org/library/papers/9325017 | PubMed |
| 3 | 1727480 | Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. | J Virol | 1992 | https://conductscience.org/library/papers/1727480 | PubMed |
| 4 | 1613662 | Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. | J Acquir Immune Defic Syndr (1988) | 1992 | https://conductscience.org/library/papers/1613662 | PubMed |
| 5 | 8456302 | Heterologous protection against influenza by injection of DNA encoding a viral protein. | Science | 1993 | https://conductscience.org/library/papers/8456302 | PubMed |
| 6 | 8176640 | Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. | J Acquir Immune Defic Syndr (1988) | 1994 | https://conductscience.org/library/papers/8176640 | PubMed |
| 7 | 8046353 | Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. | J Exp Med | 1994 | https://conductscience.org/library/papers/8046353 | PubMed |
| 8 | 7930610 | Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. | J Immunol | 1994 | https://conductscience.org/library/papers/7930610 | PubMed |
| 9 | 7998425 | HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. | Vaccine | 1994 | https://conductscience.org/library/papers/7998425 | PubMed |
| 10 | 9345075 | Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. | N Engl J Med | 1997 | https://conductscience.org/library/papers/9345075 | PubMed |
| 11 | 9367954 | Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. | Science | 1997 | https://conductscience.org/library/papers/9367954 | PubMed |
| 12 | 9543435 | A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. | AIDS | 1998 | https://conductscience.org/library/papers/9543435 | PubMed |
| 13 | 9585194 | Why do we not have an HIV vaccine and how can we make one? . | Nat Med | 1998 | https://conductscience.org/library/papers/9585194 | PubMed |
| 14 | 9585205 | HIV vaccines--where are we going? | Nat Med | 1998 | https://conductscience.org/library/papers/9585205 | PubMed |
| 15 | 9747943 | The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. | J Med Primatol | 1998 | https://conductscience.org/library/papers/9747943 | PubMed |
| 16 | 9795387 | A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. | Vaccine | 1998 | https://conductscience.org/library/papers/9795387 | PubMed |
| 17 | 9811776 | A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. | J Virol | 1998 | https://conductscience.org/library/papers/9811776 | PubMed |
| 18 | 7865283 | Mechanisms behind the immune response induced by immunostimulating complexes. | AIDS Res Hum Retroviruses | 1994 | https://conductscience.org/library/papers/7865283 | PubMed |
| 19 | 7888198 | A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. | AIDS Res Hum Retroviruses | 1994 | https://conductscience.org/library/papers/7888198 | PubMed |
| 20 | 7638218 | Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7638218 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27880897 | Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer. | Cell Rep | 2016 | https://conductscience.org/library/papers/27880897 | PubMed |
| 24670321 | Modulation of HIV-1 immunity by adjuvants. | Curr Opin HIV AIDS | 2014 | https://conductscience.org/library/papers/24670321 | PubMed |
| 22595192 | MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice. | Int Immunopharmacol | 2012 | https://conductscience.org/library/papers/22595192 | PubMed |
| 22291921 | Elicitation of neutralizing antibodies directed against CD4-induced epitope(s) using a CD4 mimetic cross-linked to a HIV-1 envelope glycoprotein. | PLoS One | 2012 | https://conductscience.org/library/papers/22291921 | PubMed |
| 22216149 | Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodies. | PLoS One | 2011 | https://conductscience.org/library/papers/22216149 | PubMed |
| 20872839 | Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2011 | https://conductscience.org/library/papers/20872839 | PubMed |
| 19895847 | The ABC of clinical and experimental adjuvants--a brief overview. | Immunol Lett | 2010 | https://conductscience.org/library/papers/19895847 | PubMed |
| 19321617 | Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody. | J Virol | 2009 | https://conductscience.org/library/papers/19321617 | PubMed |
| 15016855 | Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection. | J Virol | 2004 | https://conductscience.org/library/papers/15016855 | PubMed |
| 15008967 | Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM. | Clin Exp Immunol | 2004 | https://conductscience.org/library/papers/15008967 | PubMed |
| 14641916 | Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity. | J Immune Based Ther Vaccines | 2003 | https://conductscience.org/library/papers/14641916 | PubMed |
| 14557642 | Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. | J Virol | 2003 | https://conductscience.org/library/papers/14557642 | PubMed |
| 11925610 | Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine. | World J Gastroenterol | 2002 | https://conductscience.org/library/papers/11925610 | PubMed |
| 10756013 | Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy. | J Virol | 2000 | https://conductscience.org/library/papers/10756013 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10074183
GET https://conductscience.org/api/papers/v1/10074183/references?page=2